Irish Government hopes to begin rollout of Covid vaccine before end of year

The European Medicines Agency (EMA) has announced a potential change in the timeline for the final consideration of the Pfizer vaccine, moving the meeting date from December 29th to December 21st. If the meeting results in a positive evaluation, the EMA could authorize the vaccine within days. A flexible plan is in place to accommodate this change, allowing for the possibility of initial vaccinations before the new year, albeit at a low level.

What was the original date set by the EMA for the final consideration of the Pfizer vaccine?

• December 15th

• January 1st

• December 29th

• December 21st

When is the newly scheduled meeting by the EMA to discuss the Pfizer vaccine?

• December 29th

• December 21st

• January 5th

• December 15th

What is likely to happen if the EMA gives a positive view of the vaccine?

• The vaccine will be sent for further testing

• The vaccine will be delayed until next year

• The vaccine will be authorized in a few days

• The vaccine will be rejected

What is the nature of the plan in place for the vaccine authorization?

• Dependent on other countries' decisions

• Rigid and unchangeable

• Flexible to accommodate changes

• Only applicable after the new year

If the vaccine is authorized, when could initial vaccinations potentially begin?

• Before the new year

• In the middle of next year

• After the new year

• In two years